Guardant Health Inc (NAS:GH)
$ 23.52 -0.08 (-0.34%) Market Cap: 2.89 Bil Enterprise Value: 3.21 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 69/100

Guardant Health Inc at Cowen Health Care Conference Transcript

Mar 08, 2023 / 03:30PM GMT
Release Date Price: $28.88 (-3.09%)
Max Masucci
TD Cowen, Research Division - MD & Senior Research Analyst

Thanks everybody for being here on day 3 TD Cowen's 43rd Annual Confrence. I'm pleased to be joined by Guardant Health with CEO, Helmy Eltoukhy and CFO, Mike Bell, who probably do not need an in-depth introduction. But maybe just to kick off, you did just report results. What do you consider the headline takeaways from '22?

Helmy Eltoukhy
Guardant Health, Inc. - Co-Founder, Co-CEO & Chairman

Yes. So we had, I think, an excellent year, 42% growth in terms of clinical volume. I think overall 20% growth in terms of revenue and then obviously, making tangible progress in terms of these new emerging areas of MRD and obviously, a successful readout of Eclipse. And so I think '22 was a pivotal year with a 10-year anniversary from founding the company, and they had really brought to kind of tangible reality. There's a vision of really transforming the entire continuum of cancer care from beginning to end. And so now we have, I think, 3 franchises that are truly disruptive and have

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot